Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin versus placebo feasibility trial in cardiac surgery
ACTRN12624001325594Phase 3Not yet recruiting
- Sponsor
- ANZCA Clinical Trials Network
- Start
- Nov 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypotension comparing Vasopressin infusion with Placebo infusion (2 arms). Primary endpoints: Duration of study drug infusion, Protocol adherence and 1 more. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
vasopressin
03
Conditions
hypotension
Beyond the preview
Go deeper on ACTRN12624001325594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001325594.